pcDNA3-sACE2-WT(732)-8h Citations (3)

Originally described in: Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, Herbert AS, Procko E Science. 2020 Sep 4;369(6508):1261-1265. doi: 10.1126/science.abc0870. Epub 2020 Aug 4. PubMed Journal

---

Articles Citing pcDNA3-sACE2-WT(732)-8h

Articles
Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo. Kayabolen A, Akcan U, Ozturan D, Ulbegi-Polat H, Sahin GN, Pinarbasi-Degirmenci N, Bayraktar C, Soyler G, Sarayloo E, Nurtop E, Ozer B, Guney-Esken G, Barlas T, Yildirim IS, Dogan O, Karahuseyinoglu S, Lack NA, Kaya M, Albayrak C, Can F, Solaroglu I, Bagci-Onder T. Adv Sci (Weinh). 2022 Sep;9(27):e2201294. doi: 10.1002/advs.202201294. Epub 2022 Jul 27. PubMed
hACE2-Induced Allosteric Activation in SARS-CoV versus SARS-CoV-2 Spike Assemblies Revealed by Structural Dynamics. Chen C, Zhu R, Hodge EA, Diaz-Salinas MA, Nguyen A, Munro JB, Lee KK. ACS Infect Dis. 2023 Jun 9;9(6):1180-1189. doi: 10.1021/acsinfecdis.3c00010. Epub 2023 May 11. PubMed
Bispecific antibodies provide broad neutralization of emerging beta-coronaviruses by targeting ACE2 and viral spikes. Li M, Zhao C, Shi J, Wang X, Liu Y, Zhao X, Cai G, Chu H, Wang P. Emerg Microbes Infect. 2024 Dec;13(1):2404166. doi: 10.1080/22221751.2024.2404166. Epub 2024 Sep 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.